ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly net cash provided by / (used for) financing activities ($M) ($M)
Quarterly figures from Eli Lilly's filings and investor materials
Latest, Q2 2026
8,426
Period ended Jun 30, 2026
Change on a year earlier
-776.8%
-1,245 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
54
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash provided by / (used for) financing activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 8,426 | -776.8% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | -3,470 | -351.4% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | -2,879 | +1,176.6% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 531 | +151.2% | Form 10-Q (filed 2026-08-05) ↗ |
| Q2 2025 | Jun 30, 2025 | -1,245 | -180.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,380 | -543.3% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | -226 | -106.4% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 211 | -63.1% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,556 | -250.5% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | -311 | -175.5% | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,545 | -410.6% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 572 | -145.3% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | -1,033 | +735.4% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 412 | -114.3% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | -1,141 | -25.2% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | -1,263 | +172.7% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | -124 | -88.6% | Form 10-Q (filed 2022-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | -2,878 | +171.9% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Dec 31, 2021 | -1,527 | +18.2% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | -463 | +66.0% | Form 10-Q (filed 2021-10-27) ↗ |
| Q2 2021 | Jun 30, 2021 | -1,083 | -35.3% | Form 10-Q (filed 2021-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | -1,058 | -1,091.9% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | -1,292 | +16.0% | Form 10-K (filed 2021-02-17) ↗ |
| Q3 2020 | Sep 30, 2020 | -279 | -83.5% | Form 10-Q (filed 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | -1,673 | +88.9% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 107 | -92.2% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | -1,114 | -32.1% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | -1,693 | -491.2% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | -886 | +6.5% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,368 | -135.4% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | -1,640 | +202.4% | Form 10-K (filed 2019-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | 433 | -13.6% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | -831 | -178.4% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | -3,867 | +341.5% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | -542 | -240.8% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 501 | -183.4% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | 1,060 | +83.0% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | -876 | -5.2% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | 385 | -144.2% | Form 10-Q (filed 2017-10-27) ↗ |
| Q3 2016 | Sep 30, 2016 | -600 | +0.8% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2016 | Jun 30, 2016 | 579 | -161.4% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | -924 | +31.8% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2015 | Dec 31, 2015 | -871 | -156.7% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2015 | Sep 30, 2015 | -595 | +46.6% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | -943 | +34.3% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | -701 | +17.8% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 1,537 | – | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2014 | Sep 30, 2014 | -406 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | -703 | +31.6% | Form 10-Q (filed 2014-07-28) ↗ |
| Q1 2014 | Mar 31, 2014 | -595 | -65.6% | Form 10-Q (filed 2014-04-28) ↗ |
| Q2 2013 | Jun 30, 2013 | -534 | -3.4% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | -1,730 | -15.9% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | -1,265 | – | Form 10-K (filed 2013-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | -545 | -45.8% | Form 10-Q (filed 2012-10-26) ↗ |
| Q2 2012 | Jun 30, 2012 | -553 | – | Form 10-Q (filed 2012-07-27) ↗ |
| Q1 2012 | Mar 31, 2012 | -2,057 | +188.2% | Form 10-Q (filed 2012-04-30) ↗ |
| Q2 2011 | Sep 30, 2011 | -1,005 | +155.3% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | -714 | +30.5% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | -550 | -51.3% | Form 10-K (filed 2011-02-22) ↗ |
| Q3 2010 | Sep 30, 2010 | -394 | -56.9% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | -532 | -52.2% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | -547 | -77.0% | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | -1,129 | -126.3% | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2009 | Sep 30, 2009 | -913 | +61.4% | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2009 | Jun 30, 2009 | -1,112 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q1 2009 | Mar 31, 2009 | -2,380 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2008 | Dec 31, 2008 | 4,297 | – | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2008 | Sep 30, 2008 | -566 | – | Form 10-Q (filed 2009-10-30) ↗ |
Breakdown
What makes up net cash provided by / (used for) financing activities ($m)
- Dividends paid to shareholders ($M)1,546 · Q2 2026
- Purchases of common stock / share repurchases ($M)1,601 · Q2 2026
- Issuances of long-term debt ($M)8,941 · Q2 2026
- Repayments of long-term debt ($M)873 · Q2 2026
- Net change in short-term borrowings ($M)3,509 · Q2 2026
- Other financing activities, net ($M)-4 · Q2 2026
Cite this data
StockData. (2026). Eli Lilly Net cash provided by / (used for) financing activities ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_fcf_fin
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.